Introduction {#s1}
============

Weaning removes young pigs from the passive immune protection they receive from the milk of the sow and increases their susceptibility to enterotoxigenic *E. coli* infection [@pone.0104192-Yin1]. Early-weaned pigs often exhibit an underdeveloped immune system, digestive disorders and post-weaning diarrhea [@pone.0104192-Fairbrother1]. Enterotoxigenic *E. coli* not only colonize the small intestine, but can also release enterotoxins to stimulate epithelial cells to secrete fluid into the lumen of the gut to cause diarrhea [@pone.0104192-Liu1]. Therefore, antibiotics are often added to the diet of weanling piglets to prevent infectious disease and improve growth. However, it has been suggested that the continuous use of antibiotics may contribute to a reservoir of drug-resistant bacteria which may be capable of transferring their resistance to pathogenic bacteria in both animals and humans [@pone.0104192-vanderFelsKlerx1]. In addition, consumers are becoming increasingly concerned about the presence of drug residues in livestock products. As a result, many countries have either banned or are in the process of banning the use of antibiotics in pig diets as a routine method for promoting growth.

The pro-inflammatory cytokines IL-1β, IL-6 and TNF-α play a central role in the cell-mediated immune response, and also participate in the maintenance of tissue integrity [@pone.0104192-Splichal1]. The level of fecal calprotectin is a sensitive and non-invasive marker of active inflammation in the gastrointestinal system [@pone.0104192-vonRoon1]. Fecal calprotectin may be increased under various conditions, such as inflammatory bowel disease. TLR4, a key receptor for commensal recognition in gut innate immunity, is over-expressed in inflamed colonocytes and is the subject of therapy (target inhibition) in inflammatory bowel disease [@pone.0104192-Heimesaat1].

Several reports have described the effects of COS on growth [@pone.0104192-Tang1], immunity [@pone.0104192-Yin1], and oxidative stress [@pone.0104192-Anandan1], as well as the antimicrobial [@pone.0104192-Rabea1], hypolipidemic [@pone.0104192-Kobayashi1], and particularly the anti-inflammatory activities of COS both *in vitro* [@pone.0104192-Yoon1], [@pone.0104192-Pangestuti1]and *in vivo* [@pone.0104192-Fernandes1], [@pone.0104192-Qiao1]. The anti-inflammatory effect of COS *in vitro* has been shown to positively correlate with its molecular weight (MW) and degree of deacetylation (DD) [@pone.0104192-Lee1]. Chitosan has been shown to have specific immunomodulatory effects: i.e., it can polarize the cytokine balance toward Th1 cytokines, decrease the production of the inflammatory cytokines IL-6 (interleukin-6) and TNF-α, down-regulate CD44 and TLR4 receptor expression, and inhibit T cell proliferation [@pone.0104192-Chen1]. However, it is still unclear whether dietary supplementation with COS can alleviate inflammatory bowel diseases and how COS affects intestinal inflammation. Our previous studies showed that supplemental COS in weaned piglets decreased the feed conversion ratio and improved the intestinal morphology, intestinal connectivity, and intestinal mucosal immunity [@pone.0104192-Xiao1]. We established an *Escherichia coli* model of post-weaning diarrhea in early-weaned piglets, and used this new model to investigate the effects of COS on intestinal inflammation by daily monitoring of diarrhea and analyzed the effects of COS on inflammatory responses by determining TLR4 and calprotectin protein expression, as well as the concentration and mRNA expression of IL-1β, IL-6 and TNF-α.

Materials and Methods {#s2}
=====================

Animals and experimental design {#s2a}
-------------------------------

Animals and experimental design were same with the previous reported paper [@pone.0104192-Xiao1]. Thirty 21-day-old piglets (Duroc×Landrace×Yorkshire, initial BW of 5.65±0.27) were challenged with enterotoxigenic *Escherichia coli* during a preliminary trial period. The piglets were then randomly assigned into three groups with 10 piglets in each group. The piglets in the control group (A group) were fed the basal diet without any supplement, those in the chlortetracycline group (B group) were fed the basal diet plus 50 mg/kg chlortetracycline, and those in the COS group (C group) were fed the basal diet plus 300 mg/kg COS. The basal diets were formulated based on NRC requirements (National Research Council, 1998), and their compositions and nutritional levels are listed in [Table 1](#pone-0104192-t001){ref-type="table"}. Each group of piglets was fed their respective diet for 21 days. COS (molecular weight \<5,000 Da and degree of deacetylation \>90%) was provided by Dalian Chemical and Physical Institute (Chinese Academy of Sciences, city, China) and has a 6-sugar unit of N-acetyl glucosamine with β-(1--4)-linkages. Chlortetracycline was provided by Jinhe Biotechnology Co., Ltd. (city, China).
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###### Composition and nutrient levels of the basal diet (DM basis) %.

![](pone.0104192.t001){#pone-0104192-t001-1}

  Items                                              Content
  ------------------------------------------------- ---------
  Ingredients                                       
  Corn                                                58.42
  Soybean meal                                        25.00
  Fish meal                                           5.00
  Whey powder                                         4.00
  Cream powder                                        5.00
  Limestone                                           0.30
  CaHPO~4~                                            1.10
  Moldproofant                                        0.10
  Antioxidant                                         0.02
  Vitamin premix[1)](#nt101){ref-type="table-fn"}     0.04
  Choline chloride                                    0.08
  Mineral premix[2)](#nt102){ref-type="table-fn"}     0.30
  NaCl                                                0.30
  Flavor                                              0.06
  L-Lys HCl                                           0.23
  Met                                                 0.05
  Total                                              100.00
  Calculation composition                           
  DE (MJ/kg)                                          14.3
  CP (%)                                              19.00
  Ca (%)                                              0.58
  AP (%)                                              0.42
  Lys (%)                                             1.20
  Met (%)                                             0.40
  Thr (%)                                             0.85

Provided additional vitamins per kilogram diet: VA 11 000 IU, VD~3~ 1 100 IU, VE 16 IU, VK 1 mg, pantothenate 6 mg, retinoic acid 2 mg, folic acid 0.8 mg, nicotinic acid 10 mg, thiamine 0.6 mg, VB~1~ 0.6 mg, biotin 0.08 mg, VB~12~ 0.03 mg.

Provided with additional trace elements per kilogram diet: Zn 165 mg, Fe 165 mg, Mn 33 mg, Cu 16.5 mg, I 297 µg, Se 297 µg.

Piglets were randomly allocated into pens with one pig per pen in a temperature-controlled room, as described by Tang et al. Feed was provided to the piglets three times per day at 8:00, 12:00 and 18:00, and any uneaten food was weighed in the morning of the next day. Feed and water were provided *ad libitum*. The piglets were checked daily for signs of disease and mortality. The animals were weighed individually, and feed intake and feed efficiency were determined for each pen on a weekly basis to monitor the growth of animals fed the different diets. At the end of the 21-day period of feeding with the experimental diets, six piglets per treatment were sacrificed for sampling. The animal protocol was approved by the Animal Care Committee of the Institute of Subtropical Agriculture, the Chinese Academy of Sciences.

Sampling and sample processing procedures {#s2b}
-----------------------------------------

Six piglets from each treatment group were sacrificed after feed deprivation for 12 h by the injection of 4% sodium pentobarbital solution (40 mg/kg BW) for the collection of tissue samples on day 21 post-weaning. Blood samples were taken from the heart, and were centrifuged at 3000 rpm for 10 minutes, then, the serums were collected and stored at −80°C. The small intestine (SI) was removed and its length was determined; the jejunum was considered to be located at about 50% of the length of the SI. About 3 g of jejunal mucosa was collected immediately, frozen in liquid nitrogen, and stored at −80°C until the extraction of total RNA. Four cm-long segments were excised from the jejunum and fixed in 4% formaldehyde for subsequent morphological and immunohistochemical analysis.

Diarrhea index {#s2c}
--------------

The piglets\' stool was observed when they were fed, and those that had thin, soft feces were considered to have diarrhea. Diarrhea index (%) was calculated as 100× number of piglets that had diarrhea/total number of piglets.

Enzyme-linked immunosorbent assay (ELISA) {#s2d}
-----------------------------------------

Cytokines including IL-1β, IL-6 and TNF-α in serum were measured by an ELISA kit (R & D Systems, Wiesbaden-Nordenstadt, Germany) according to the manufacturer\'s instructions.

Immunohistochemistry and relative quantitative real-time PCR {#s2e}
------------------------------------------------------------

Calprotectin and TLR4 protein expression in the jejunal mucosa were detected by immunohistochemistry. The mRNA expression of IL-1β, IL-6 and TNF-α in the jejunal mucosa were detected by relative quantitative real-time PCR and the results were presented as fold changes using the 2^−ΔΔCT^ method ([Table 2](#pone-0104192-t002){ref-type="table"}). Those methods were reported in the previous paper [@pone.0104192-Xiao1].

10.1371/journal.pone.0104192.t002

###### Sequences (5′--3′) of the primers used for the detection of mRNA specific for IL-1β, IL-6, TNF-α and GAPDH.
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  Gene     Accession number   Primer sequences (5′ to 3′)   Product size (bp)
  ------- ------------------ ----------------------------- -------------------
  GAPDH        AF017079         F: GAAGGTCGGAGTGAACGGAT            149
                              R: CATGGGTAGAATCATACTGGAACA  
  IL-1β      NM_214055.1        F: GAAAGATAACACGCCCACCC            165
                               R: TCTGCTTGAGAGGTGCTGATGT   
  IL-6       NM_214399.1       F: TCCAGAAAGAGTATGAGAGCA            177
                                R: TCTTCATCCACTCGTTCTGT    
  TNF-α      NM_214022.1       F: CCACGCTCTTCTGCCTACTGC            168
                                R: GCTGTCCCTCGGCTTTGAC     

Notes: F = forward primer; R = reverse primer.

Statistical Analysis {#s2f}
--------------------

The data was analyzed by analysis of variance (ANOVA) using the general linear model (GLM) procedure of the statistical analysis system (SAS) programs (9.1). Duncan\'s multiple range test was applied for comparing the differences among treatments. The difference was considered to be significant at *P*\<0.05, and be very significant at *P*\<0.01.

Results {#s3}
=======

Diarrhea {#s3a}
--------

As presented in [Fig. 1](#pone-0104192-g001){ref-type="fig"}, the diarrhea frequency slowly decreased as the experiment progressed, and four piglets had diarrhea at the end of the feeding trial in the control group. In the chlortetracycline group, five piglets had diarrhea on the fifth day, and from day 17 to the end, two piglets had diarrhea; In the COS group, from day 14 to the end, none of the piglets had diarrhea. The results showed that 300 mg/kg COS had a similar effect (*P*\>0.05) on reducing diarrhea as 50 mg/kg chlortetracycline.

![Changes in diarrhea index in piglets.\
Piglets challenged by enterotoxigenic *Escherichia* coli were fed either a control diet (A group, n = 10), or control diet plus chlortetracycline (B group, n = 10) or control diet plus chitosan (C group, n = 10) for 21 days. Diarrhea index (%) was calculated as 100× number of piglets that had diarrhea/total number of piglets.](pone.0104192.g001){#pone-0104192-g001}

Inflammatory cytokines {#s3b}
----------------------

The concentrations of IL-1β, IL-6 and TNF-α in serum were not affected by any of the treatments ([Table 3](#pone-0104192-t003){ref-type="table"}).

10.1371/journal.pone.0104192.t003

###### Serum IL-1β, IL-6 and TNF-α levels in weaned piglets.
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  Items                     Treatments[1](#nt104){ref-type="table-fn"}    SEM    *P*-value          
  ------------------------ -------------------------------------------- ------- ----------- ------- --------
  IL-1β (ng/L)                                58.36                      65.14     61.65     1.783   0.3000
  IL-6 (ng/L)                                 57.20                      63.35     67.30     1.808   0.133
  TNF-α (ng/L)                                54.84                      60.01     61.34     1.709   0.441
  Number of observations                        6                          6         6              

A group means the control group, B group means the chlortetracycline group, C group means the COS group.

Jejunal mucosal calprotectin and TLR4 protein expression {#s3c}
--------------------------------------------------------

The color signals of jejunal mucosal calprotectin and TLR4 protein expression in the COS group were lighter than those in both the control and chlortetracycline groups ([Figure 2](#pone-0104192-g002){ref-type="fig"}). The integral optical density of calprotectin and TLR4 protein expression in the COS group was lower (*P*\<0.05) than those in both the control and chlortetracycline groups, and there was no difference between the chlortetracycline group and the control group ([Table 4](#pone-0104192-t004){ref-type="table"}).

![Calprotectin and TLR4 protein expression in jejunal mucosa (immunohistochemical staining, ×400).\
Piglets challenged by enterotoxigenic *Escherichia* coli were fed either a control diet (A group, n = 6), or control diet plus chlortetracycline (B group, n = 6) or control diet plus chitosan (C group, n = 6) for 21 days and 6 pigs per treatment were killed to excise the jejunum.](pone.0104192.g002){#pone-0104192-g002}

10.1371/journal.pone.0104192.t004

###### Integral optical density of Calprotectin and TLR4 protein expression in jejunal mucosa.

![](pone.0104192.t004){#pone-0104192-t004-4}

  Items                                                          Treatments[1](#nt106){ref-type="table-fn"}                    SEM                                   *P*-value                         
  ------------------------------------------------------------- -------------------------------------------- ---------------------------------------- ---------------------------------------- ------- --------
  Integral optical density of Calprotectin protein expression      389.68[a](#nt105){ref-type="table-fn"}     327.54[b](#nt105){ref-type="table-fn"}   338.65[b](#nt105){ref-type="table-fn"}   17.49   0.0285
  Integral optical density of TLR4 protein expression              250.51[a](#nt105){ref-type="table-fn"}     202.30[b](#nt105){ref-type="table-fn"}   212.94[b](#nt105){ref-type="table-fn"}   12.52   0.0397
  Number of observations                                                             6                                          6                                        6                             

Means with different superscripts in the same row differ (*P*\<0.05).

A group means the control group, B group means the chlortetracycline group, C group means the COS group.

Jejunal mucosal IL-1β, IL-6 and TNF-α mRNA expression {#s3d}
-----------------------------------------------------

There was no difference in the relative expression level of jejunal mucosal TNF-α mRNA among the three groups ([Figure 3](#pone-0104192-g003){ref-type="fig"}). The relative expression level of jejunal mucosal IL-6 mRNA in the COS group was higher (*P*\<0.05) than that in the control group. There was no difference between the chlortetracycline group and the COS group ([Figure 3](#pone-0104192-g003){ref-type="fig"}). The relative expression level of jejunal mucosal IL-1β mRNA in the COS group was higher (*P*\<0.05) than that in the chlortetracycline group. There was no difference between the chlortetracycline group and the COS group ([Figure 3](#pone-0104192-g003){ref-type="fig"}).

![The relative expression of IL-1β, IL-6 and TNF-α mRNA in jejunal mucosa.\
Piglets challenged by enterotoxigenic *Escherichia* coli were fed either a control diet (A group, n = 6), or control diet plus chlortetracycline (B group, n = 6) or control diet plus chitosan (C group, n = 6) for 21 days and 6 pigs per treatment were killed to excise the jejunum.](pone.0104192.g003){#pone-0104192-g003}

Discussion {#s4}
==========

The present study established an excellent piglet diarrhea model for intestinal disorder and demonstrated a clear difference between the effects of COS or chlortetracycline on intestinal inflammation. Chito-oligosaccharide reduced the incidence of diarrhea, but the growth performance of *E. coli*-challenged pigs supplemented with 160 mg of chito-oligosaccharide was not better than that of unsupplemented pigs challenged with *E. coli* K88. Dietary supplementation with COS at 100 and 200 mg/kg enhanced growth performance by increasing apparent digestibility, decreasing the incidence of diarrhea, and improving the small intestine morphology [@pone.0104192-Liu2].

In essence, the danger model proposes that endogenous host-derived molecules from damaged cells and tissues activate the immune system to cause a systemic inflammatory response. Activation of the corresponding receptors in turn results in the production of pro-inflammatory and tissue-injurious mediators [@pone.0104192-Reino1]. Toll-like receptors (TLRs) are an important class of pattern recognition receptors (PRRs) in innate immunity, and play a critical role in pathogen recognition and host defense [@pone.0104192-Shimazu1]. TLR4 activation and cytokine production by intestinal epithelial cells (IECs) can induce the recruitment and activation of inflammatory cells, and prolonged or dysregulated pro-inflammatory cytokine production may lead to tissue damage and epithelial barrier dysfunction [@pone.0104192-Hormannsperger1]. TLR4 plays a major role in controlling inflammation through the inhibition of mitogen-activated protein kinase (p38 and c-Jun N-terminal kinase) and NF-κB signaling pathways [@pone.0104192-Byun1]. TLR4 activation has been shown to be involved in the pathogenesis of acute tissue injury and the induction of a systemic inflammatory state [@pone.0104192-Mollen1]. An important biological consequence of TLR signalling is the production of chemoattractants, which leads to the recruitment of inflammatory cells to the site of exposure [@pone.0104192-Sahlander1]. Therefore, this piglet diarrhea model was useful for studying TLR4-mediated inflammatory responses in the intestine. Our earlier work showed that COS supplementation decreased the expression of *TLR4* mRNA, and our current work extends these findings by demonstrating that COS supplementation decreased TLR4 protein expression, which indicates that COS supplementation can efficiently activate an inflammatory immune response, thus reducing intestinal infection.

Calprotectin is a cytosolic protein in the S-100 protein group; its levels increase under conditions such as inflammation, infection, and malignancy. It has immunomodulatory, antimicrobial and antiproliferative action and is predominantly found in neutrophils, monocytes and macrophages, as well as (to a lesser extent) in T and B lymphocytes [@pone.0104192-Beser1]. Fecal calprotectin is a promising marker of neutrophilic intestinal inflammation [@pone.0104192-Costa1], and correlates well with the severity of inflammation, as judged by both endoscopic and histological scoring systems [@pone.0104192-Konikoff1]. It has been consistently shown to be elevated in patients with known irritable bowel disease (IBD), and has an excellent negative predictive value in ruling out IBD in under-diagnosed symptomatic patients. The degree of inflammation has been shown to be strongly associated with calprotectin-positive cells in the stomach [@pone.0104192-Choi1]. *E. coli* elicited a significant increase in the calprotectin level, which was confirmed by immunofluorescence and immunohistochemistry, and the calprotectin level is an important indicator of inflammatory bowel disease [@pone.0104192-Splichal1]. Calprotectin is an abundant neutrophil protein that is released during inflammation. Since calprotectin correlates well with the degree of inflammation, the results of the current study demonstrated that supplementation with COS and chlortetracycline efficiently decreased calprotectin protein expression, and therefore inhibited inflammation and decreased diarrhea in piglets.

Proinflammatory cytokines emanating from the immune system can have profound effects on the neuroendocrine system, either by gaining direct access to the central nervous system or by triggering the synthesis of cytokines by cells in the central nervous system [@pone.0104192-Liu3]. Inflammatory activation (IL-1β or TNF-α) of astrocytes results in the transient production of key inflammatory mediators including IL-6, cell surface adhesion molecules, and various leukocyte chemoattractants [@pone.0104192-vanKralingen1]. Lower levels of IL-6 help to regulate the recruitment and activity of inflammatory cells and limit inflammatory damage. As an innate immune receptor, TLR4 activates NF-κB through recruitment of the adaptor proteins myeloid differentiation primary response gene 88 (MyD88) and Toll/interleukin 1 receptor domain-containing adaptor protein inducing IFN-β (TRIF), which leads to the subsequent induction of NF-κB signalling genes, such as TNF-α, IL-1 and IL-6 [@pone.0104192-Dou1]. The complex network of cytokines regulates the immune response in the host to prevent susceptibility to disease and enhance resistance to infections. Logically, up-regulation of the protein expression of TLR4 should indicate that the TLR4 signaling pathway is inhibited, and its downstream cytokines including IL-1β, IL-6 and TNF-α should decrease. However, IL-1β and IL-6 mRNA expression improved in that study. Moreover, that study supported our present study in that COS supplementation promoted IL-1β and IL-6 expression, while COS did not affect either TNF-α mRNA expression in the jejunal mucosa, or the levels of IL-1β, IL-6 and TNF-α in serum. We can speculate on possible reasons for these results: In response to peripheral challenge with enterotoxigenic *E. coli*, comprehensive inflammation may have been elicited in weaned piglets; a variety of cells in the immune system may have secreted high concentrations of proinflammatory cytokines. COS supplementation enhances the cell-mediated immune response by modulating the production of cytokines, but some time is needed before TLR4 can activate its downstream signaling pathway. Therefore, IL-1β and IL-6 mRNA expression in intestinal mucosa were still quite high when the piglets were slaughtered. This result is consistent with a previous report that supplementation with COS and chlortetracycline have similar effects in reducing intestinal inflammation, but different effects on intestinal mucosal barrier function [@pone.0104192-Xiao1].

In summary, we can propose a mechanism by which COS can inhibit diarrhea: after chitosan adheres to the intestinal mucosa, its amine is recognized by the immune system. Immune response pathways are activated, and the gut-associated lymphoid immune system is stimulated to produce lymphokines and inflammatory mediators, secrete cytokines IL-1, IL-6, etc., reduce calprotectin and TLR4 protein expression, and enhance the cell-mediated immune response. Therefore, COS helps to prevent inflammatory intestinal disorders, including weaning-associated intestinal inflammation. Furthermore, our previous paper reported that diets supplemented with COS or chlortetracycline could improve intestinal mucosal morphology and occludin protein expression [@pone.0104192-Xiao1]. Thus, the digestion and absorption of nutrients in the intestine are improved in piglets. These may be contributing factors for chitosan to decrease diarrhea.

In conclusion, we have demonstrated that supplementation with COS and chlortetracycline can decrease the occurrence of diarrhea and alleviate intestinal inflammation by up-regulating TLR4 and calprotectin protein expression in weaned piglets challenged with enterotoxigenic *Escherichia* coli. In addition, COS can enhance the cell-mediated immune response by modulating the production of inflammatory cytokines.
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